Amyloidosis in a patient with autosomal dominant polycystic kidney disease and tuberculosis: a case report

[1]  P. Hawkins,et al.  Drug Insight: emerging therapies for amyloidosis , 2006, Nature Clinical Practice Nephrology.

[2]  Giampaolo Merlini,et al.  Molecular mechanisms of amyloidosis. , 2003, The New England journal of medicine.

[3]  K. Tsuchiya,et al.  Secondary systemic amyloidosis associated with frequently infected hepatic cysts in a patient with autosomal dominant polycystic kidney disease. , 2003, Clinical Nephrology.

[4]  Yong-ji Wu,et al.  [A clinical analysis of 71 cases of amyloidosis]. , 2003, Zhonghua nei ke za zhi.

[5]  E. Hachulla,et al.  Diagnostic tools for amyloidosis. , 2002, Joint, bone, spine : revue du rhumatisme.

[6]  S. Paydaş,et al.  A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  J. Martínez-Ara,et al.  [Recurrence and spontaneous remission of nephrotic syndrome in secondary renal amyloidosis]. , 2002, Nefrología.

[8]  N. Gretz,et al.  An endocytosis defect as a possible cause of proteinuria in polycystic kidney disease. , 2001, American journal of physiology. Renal physiology.

[9]  I. Castellano,et al.  [Remission of nephrotic syndrome caused by renal amyloidosis secondary to pulmonary tuberculosis after tuberculostatic treatment]. , 2001, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[10]  I. Ebihara,et al.  Effects of the Angiotensin II Receptor Antagonist Candesartan Cilexetil on Blood Pressure and Proteinuria in Patients with Autosomal Dominant Polycystic Kidney Disease , 2000, Nephron.

[11]  H. Fadel,et al.  [Prevalence of subcutaneous, labial and rectal amyloid lesions in patients wi histologically confirmed renal amyloidosis]. , 2000, Nephrologie.

[12]  J. Grünfeld Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  V. Shah,et al.  Renal amyloidosis--a clinicopathologic study. , 1996, Indian journal of pathology & microbiology.

[14]  J. Ortuño,et al.  Proteinuria and hypertension in autosomal dominant polycystic kidney disease. , 1996, Nephron.

[15]  V. Pardo,et al.  Nephrotic syndrome in autosomal dominant polycystic kidney disease. , 1995, Journal of the American Society of Nephrology : JASN.

[16]  Ann M. Johnson,et al.  Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. , 1994, Journal of the American Society of Nephrology : JASN.

[17]  P. Bass,et al.  Autosomal dominant polycystic kidney disease complicated by glomerulonephritis. , 1992, Nephron.

[18]  A. Mazuecos,et al.  Nephrotic syndrome and focal glomerulosclerosis in adult polycystic kidney disease. , 1992, Nephron.

[19]  H. Makino,et al.  A membranous nephropathy associated with adult polycystic kidney disease. , 1991, Clinical nephrology.

[20]  H. Nakahama,et al.  A case of polycystic kidney disease with nephrotic syndrome. , 1991, Urologia internationalis.

[21]  A. Tzamaloukas,et al.  Nephrotic syndrome and rapid renal failure in autosomal dominant polycystic kidney disease. , 1990, American journal of nephrology.

[22]  G. Bono,et al.  Familial amyloid polyneuropathy: report of an autopsy case with neuropathy, vitreous opacities and polycystic kidney. , 1989, European neurology.

[23]  S. Adler,et al.  Autosomal dominant polycystic kidney disease: presentation, complications, and prognosis. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  M. Skinner,et al.  Bleeding manifestations in 100 patients with amyloidosis. , 1983, JAMA.

[25]  M. Labeeuw,et al.  The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases. , 1982, Clinical nephrology.